Mumbai: Bajaj Healthcare Limited has announced that it has received approval from the Drug Controller General of India (DCGI) ...

Bajaj Healthcare receives DCGI approval to manufacture Pimavanserin, a generic medication for treating hallucinations and delusions associated with Parkinson's disease.

Bajaj Healthcare said that it has received approval from the Drug Controller General of India (DCGI) to manufacture both the API and drug formulation of Pimavanserin.

Bajaj Health has also extended the offer for Pimavanserin to several leading pharma companies to ensure availability in ...

Bajaj Healthcare has received an approval from the Drug Controller General of India (DCGI) to manufacture both the API and Drug Formulation of Pimavanserin, a 34 mg capsule.

Mizuho Securities analyst Graig Suvannavejh has maintained their bullish stance on AXSM stock, giving a Buy rating on January 24.Invest with ...

Two Wisconsin Republican lawmakers are working to prevent some insurers from forcing patients with severe mental illnesses to try cheaper antipsychotic drugs than their doctors prescribed. State Sen.

The deal provides J&J with an FDA-approved atypical antipsychotic as well as a pipeline of therapies for diseases of the central nervous system. “This unique opportunity to add Intra-Cellular ...

All these changes have to be taken into account, and they explain why, for example, elderly persons are more sensitive to benzodiazepine or antipsychotic effects, experiencing stronger sedation ...

Brexpiprazole is an atypical antipsychotic used as an adjunctive therapy to antidepressants for the treatment of major depressive disorder (MDD) in adults, and also used in treatment of schizophrenia ...

“It’s tracking ahead of all the newly launched atypical antipsychotic analogs,” Chief Commercialization Officer Adam Lenkowsky said in an interview. Those would include drugs like Vraylar ...